To the Editor, Carbamazepine is an effective anticonvulsant and has a relatively low incidence of adverse effects, although it occasionally causes hema- tologic disorders. We herein describe a patient with carbamazepine- induced thrombocytopenic purpura that was investigated by pharma- cological, immunological and genomic assays.

Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis

ABATE, MARIA VALENTINA;STOCCO, GABRIELE;PIEROBON, CHIARA;LUCAFO, MARIANNA;DI SILVESTRE, ALESSIA;D'ADAMO, ADAMO PIO;Tommasini, Alberto;DECORTI, GIULIANA
;
VENTURA, ALESSANDRO
2016-01-01

Abstract

To the Editor, Carbamazepine is an effective anticonvulsant and has a relatively low incidence of adverse effects, although it occasionally causes hema- tologic disorders. We herein describe a patient with carbamazepine- induced thrombocytopenic purpura that was investigated by pharma- cological, immunological and genomic assays.
File in questo prodotto:
File Dimensione Formato  
carbamazepine.pdf

Accesso chiuso

Tipologia: Documento in Versione Editoriale
Licenza: Digital Rights Management non definito
Dimensione 1.51 MB
Formato Adobe PDF
1.51 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Manuscript.pdf

Open Access dal 02/08/2017

Tipologia: Bozza finale post-referaggio (post-print)
Licenza: Digital Rights Management non definito
Dimensione 114.97 kB
Formato Adobe PDF
114.97 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11368/2878526
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact